Blog - Page 4611 of 5746

ThursdayJul 31, 2008 4:12 am

Lexicon Pharmaceuticals, Inc. (LXRX) Announces Positive Phase I Trial of LX1031 for Irritable Bowel Syndrome

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), a biopharmaceutical company that focuses on discovering and developing breakthrough treatments for various human disease, recently announced the successful completion of the company’s Phase 1 multiple-dose escalation study in normal volunteers with LX1031, its oral drug candidate for irritable bowel syndrome (IBS). The recently completed trial for LX13031 was a randomized, double-blind, ascending multiple-dose study in which all dose levels were well tolerated over 14 days and no dose limiting toxicities were observed. Based on the success of the Phase I trial, Lexicon Pharmaceuticals plans to progress the new drug candidate into Phase II studies…

ThursdayJul 31, 2008 4:10 am

Microtune, Inc. (TUNE) Reports Second Quarter Earnings – Expects Positive Outlook for the Third and Fourth Quarters

Microtune, Inc. (NASDAQ: TUNE), a silicon and subsystems company that designs and markets radio frequency (RF) solutions for the worldwide consumer electronics and automotive electronics markets, recently reported its financial results for the second quarter that ended June 30, 2008. Microtune’s net revenue for the second quarter totaled $26.6 million, a 7% year-over-year increase compared to net revenue of $24.8 million for the same period one year earlier. Non-GAAP net income per diluted share reached $0.06 for the second quarter versus $0.07 in the second quarter of 2007. Shares for Microtune traded higher earlier this week on the company’s strong…

WednesdayJul 30, 2008 4:31 pm

O2Micro International Limited (OIIM) Reports Better than Expected Q2 Results

O2Micro International Limited (OIIM), a leading developer of power management and security components for computers and consumer electronics, reported second quarter financial results today after the close. Revenues were $40.8 million, an increase of 6.8% from the prior year and 8.6% sequentially. GAAP net income, including the effect of $721,000 in stock-based compensation expense, was $4.4 million, or 12 cents per American Depositary Share (ADS), vs. analysts’ consensus estimate of 10 cents per ADS. Sterling Du, Chairman and CEO, commented, “During these challenging economic times, we are continuing to grow because O2Micro is bringing great new products to the market.”…

WednesdayJul 30, 2008 4:30 pm

Mega Media Group, Inc. (MMDA.OB) Heats Up With the Summer Months

Mega Media Group, Inc. (MMDA.OB) has been working diligently on marketing their subsidiary, Pulse 87 FM, during the summer months. The company's website, www.pulse87.com, launched back in May, specifically targets the demographic of 18-49 year olds. The site was created to allow listeners receive the latest and most intriguing entertainment news and updates on events, as well as listen to live broadcasts and send in music requests. The company believed a website to be a pivotal move in gaining more consumers since many of them use computers daily, and having access to the station through the web will only increase…

WednesdayJul 30, 2008 4:24 pm

QuoteMedia, Inc. (QMCI.OB) Management Team has Vast Applicable Experience

QuoteMedia, Inc. (OTCBB: QMCI) engages in the financial market data industry by delivering a complete and comprehensive financial market information and software applications with a reduced cost. The company's diversity of technical expertise, their agile responsiveness to custom corporate requirements, and their proven commitment to superior delivery technologies have positioned them as a leader within the financial market data industry. Their advanced model allows them to manage and stream information to multiple entities from major exchanges in the U.S., Canada, and Europe. Through QuoteMedia's development team, the company is able to respond rapidly to product changes and their ability to…

WednesdayJul 30, 2008 4:21 pm

Rocky Mountain Chocolate Factory, Inc. (RMCF) Reports First Quarter Operating Results

Rocky Mountain Chocolate Factory, Inc. (RMCF), a gourmet chocolate and confection manufacturer based in Durango, Colorado, has been in operation since 1982. An international franchiser and retail operator in the United States, Canada and the United Arab Emirates, the company manufactures an extensive line of premium chocolate candies and other confectionery products. Producing approximately 300 chocolate candies and other confectionery products using recipes developed primarily by its master candy maker, products include varieties of clusters, caramels, creams, mints and truffles, with an additional 100 confectionery treats during holiday seasons. Rocky Mountain reported its operating results for the first quarter of…

WednesdayJul 30, 2008 4:19 pm

DXP Enterprises, Inc. (DXPE) Reports Record Second Quarter Earnings that Beat Estimates

DXP Enterprises, Inc. (DXPE), an industrial products distributor servicing primarily the oil and gas and food and beverage industries, announced second quarter results this afternoon that topped analysts’ estimates while setting quarterly records on both the top and bottom lines. Revenues surged 120% year over year to $187.8 million vs. consensus of $172.9 million. Net income rose 86.5% to $6.37 million, or 93 cents per share, compared to analysts’ estimates of 86 cents per share. David R. Little, Chairman and Chief Executive Officer said, “We continue to execute our three-pronged growth strategy of organic growth, operational efficiencies and acquisitions. Our…

WednesdayJul 30, 2008 11:52 am

BioCurex, Inc. (BOCX) Files Provisional Patent Application

BioCurex, Inc. is actively involved with product development in cancer diagnostics, imagery, and therapeutic technologies. One of the company's prime areas of focus is its patented RECAF™ technology, which is capable of identifying the RECAF cancer marker in test subjects. The application filed by BioCurex on Tuesday includes the protection of various methods for detecting RECAF in bodily fluids. It goes on to illustrate believed advancements in the area of cancer imaging and treatment based on RECAF technology. "This new patent application is the result of several years of intense work and it reflects the value added to our company…

WednesdayJul 30, 2008 11:51 am

3DIcon Corp. (TDCP.OB) Welcomes New Chief Technology Officer

3DIcon Corporation is a developer of highly advanced 3D projection technologies for the purpose of displaying true three-dimensional, 360 degree volumetric images. 3DIcon welcomed a new CTO to its ranks this week, in acclaimed scientist Dr. Hakki Refai, whose research at the University of Oklahoma led to the development of the company's CSpace™ and Pixel Precision™ 3D technologies. Starting this quarter, Dr. Refai will be responsible for the oversight of 3DIcon's technology development, as well as working with licensing partners on the monetization of those technologies. Many believe that Dr. Refai's presence will quicken the company's pace in accomplishing its…

WednesdayJul 30, 2008 11:45 am

Oxygen Biotherapeutics Inc.’s (OXBO.OB) Upstanding Spinal Cord Oxygen Therapy featured in Major Medical Publication

According to the National Spinal Cord Injury Statistical Center, approximately 12,000 cases of spinal cord injury occur each year. The No. 1 cause of spinal cord injury is motor vehicle crashes, accounting for 42 percent of reported injuries. Acts of violence, such as gunshot wounds, and recreational sporting activities follow, respectively. Oxygen Biotherapeutics Inc. (OTCBB: OXBO) engages in the commercialization of oxygen therapeutics and related pharmaceuticals and medical devices. The company today announced that Oxycyte, the company’s perfluorocarbon (PFC) oxygen carrier, was featured in the August 2008 edition of the "Journal of Neurosurgery: Spine." The article explains how Oxycyte can…

Site Search

Company Search